Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has completed a significant capital injection of RMB493.6 million into Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. This move, involving the transfer of full equity interest in Tianjin Zhongxin Medicine Co., Ltd., aims to strengthen its position in the pharmaceutical sector. The completion follows the resolutions passed during the company’s board meeting and subsequent approvals.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.